De Leo D, Magni G
Br J Psychiatry. 1986 May;148:597-9. doi: 10.1192/bjp.148.5.597.
The action of viloxazine on libido and sex drive was evaluated with a randomised controlled double-blind trial against placebo on a population of 26 male out-patients affected by primary depression (DSM III). Modifications in the sexual sphere were assessed by the ad hoc inclusion of a series of items in the Zung Self-Rating Depression Scale. Thus modified, the scale was administered at the beginning and the end of a four-week trial period. Viloxazine proved to have a considerable disinhibiting effect, whose principal expression level was a return to pre-depression levels of frequency in sexual relations.
在一项针对26名患有原发性抑郁症(DSM III)的男性门诊患者的随机对照双盲试验中,对比安慰剂评估了维洛沙嗪对性欲和性驱力的作用。通过在zung自评抑郁量表中特别纳入一系列项目来评估性方面的变化。经过这样修改后,该量表在为期四周的试验期开始和结束时进行施测。结果证明维洛沙嗪具有相当大的去抑制作用,其主要表现水平是性关系频率恢复到抑郁前的水平。